BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11912005)

  • 1. A novel homozygous point mutation in the COL17A1 gene in a Chinese family with generalized atrophic benign epidermolysis bullosa.
    Wu Y; Li G; Zhu X
    J Dermatol Sci; 2002 Apr; 28(3):181-6. PubMed ID: 11912005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.
    Shimizu H; Takizawa Y; Pulkkinen L; Zone JJ; Matsumoto K; Saida T; Uitto J; Nishikawa T
    J Invest Dermatol; 1998 Nov; 111(5):887-92. PubMed ID: 9804354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa.
    Darling TN; McGrath JA; Yee C; Gatalica B; Hametner R; Bauer JW; Pohla-Gubo G; Christiano AM; Uitto J; Hintner H; Yancey KB
    J Invest Dermatol; 1997 Apr; 108(4):463-8. PubMed ID: 9077475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa.
    Pohla-Gubo G; Lazarova Z; Giudice GJ; Liebert M; Grassegger A; Hintner H; Yancey KB
    Exp Dermatol; 1995 Aug; 4(4 Pt 1):199-206. PubMed ID: 8535614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa.
    Pulkkinen L; Marinkovich MP; Tran HT; Lin L; Herron GS; Uitto J
    J Invest Dermatol; 1999 Dec; 113(6):1114-8. PubMed ID: 10636730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa.
    McGrath JA; Darling T; Gatalica B; Pohla-Gubo G; Hintner H; Christiano AM; Yancey K; Uitto J
    J Invest Dermatol; 1996 Apr; 106(4):771-4. PubMed ID: 8618019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.
    Huber M; Floeth M; Borradori L; Schäcke H; Rugg EL; Lane EB; Frenk E; Hohl D; Bruckner-Tuderman L
    J Invest Dermatol; 2002 Jan; 118(1):185-92. PubMed ID: 11851893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.
    Chavanas S; Gache Y; Tadini G; Pulkkinen L; Uitto J; Ortonne JP; Meneguzzi G
    J Invest Dermatol; 1997 Jul; 109(1):74-8. PubMed ID: 9204958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
    Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
    J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency.
    Jonkman MF; de Jong MC; Heeres K; Steijlen PM; Owaribe K; Küster W; Meurer M; Gedde-Dahl T; Sonnenberg A; Bruckner-Tuderman L
    Arch Dermatol; 1996 Feb; 132(2):145-50. PubMed ID: 8629821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosaic expression of uncein and 180-kDa bullous pemphigoid antigen in generalized atrophic benign epidermolysis bullosa.
    Matsumura Y; Horiguchi Y; Toda K; Fujii H; Kore-Eda S; Tachibana T; Ohta K; Okamoto H; Imamura S
    Br J Dermatol; 1997 May; 136(5):757-61. PubMed ID: 9205513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A founder COL17A1 splice site mutation leading to generalized atrophic benign epidermolysis bullosa in an extended inbred Palestinian family from Israel.
    Whittock NV; Sher C; Gold I; Libman V; Reish O
    Genet Med; 2003; 5(6):435-9. PubMed ID: 14614394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 180-kDa bullous pemphigoid antigen defective generalized atrophic benign epidermolysis bullosa: report of four cases with an unusually mild phenotype.
    Mazzanti C; Gobello T; Posteraro P; Paradisi M; Meneguzzi G; Chinni L; Zambruno G
    Br J Dermatol; 1998 May; 138(5):859-66. PubMed ID: 9666835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid antigens (BPAGs): identification of RFLPs in human BPAG1 and BPAG2, and exclusion as candidate genes in a large kindred with dominant epidermolysis bullosa simplex.
    Ryynänen M; Knowlton RG; Kero M; Sawamura D; Li KH; Giudice GJ; Diaz LA; Uitto J
    Genomics; 1991 Dec; 11(4):1025-9. PubMed ID: 1686013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.
    Darling TN; Yee C; Koh B; McGrath JA; Bauer JW; Uitto J; Hintner H; Yancey KB
    J Invest Dermatol; 1998 Feb; 110(2):165-9. PubMed ID: 9457913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa.
    Yao YY; Zhang Y; Xie XH; Chen L; Zhu F; Zhou M
    Curr Med Sci; 2020 Aug; 40(4):795-800. PubMed ID: 32862392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families.
    Nakano A; Lestringant GG; Paperna T; Bergman R; Gershoni R; Frossard P; Kanaan M; Meneguzzi G; Richard G; Pfendner E; Uitto J; Pulkkinen L; Sprecher E
    J Am Acad Dermatol; 2002 Apr; 46(4):510-6. PubMed ID: 11907499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex.
    Fontao L; Tasanen K; Huber M; Hohl D; Koster J; Bruckner-Tuderman L; Sonnenberg A; Borradori L
    J Invest Dermatol; 2004 Jan; 122(1):65-72. PubMed ID: 14962091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen.
    Pasmooij AM; van der Steege G; Pas HH; Smitt JH; Nijenhuis AM; Zuiderveen J; Jonkman MF
    Br J Dermatol; 2004 Sep; 151(3):669-74. PubMed ID: 15377356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of determining 180 kDa bullous pemphigoid antigen (BPAG2) gene/protein pathology in neonatal junctional epidermolysis bullosa.
    Mellerio JE; Denyer JE; Atherton DJ; Eady RA; McGrath JA
    Br J Dermatol; 1998 Apr; 138(4):661-6. PubMed ID: 9640376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.